I dont mind your posts, but as i previously said you need to be more evidence driven, now if you were fair in this post you would have mentioned that TLX 591 Phase 1/2 readout (safety and dosimetry) was well-tolerated with predictable and transient hematological toxicity, with subsequent recovery. it also was rapidly cleared by the liver. No patient was discontinued as a result of adverse effects
So you are just throwing mud without any evidence or indication.
Hopefully the part 1 interim readout confirms above, or maybe they are just holding it back so they can give us a more meaningful positive surprise on survival, effectiveness!!
steady she goes.
this is the calm before the great reward (hopefully)
TLX Price at posting:
$25.68 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)